Breast Cancer

Navigating Insurance Hurdles and Policy Shortfalls in Breast Cancer Care: Anasuya Gunturi, MD, PhD

Breast Cancer Treatment Transformed With HER2 Identification: Michael Hassett, MD, MPH

Shaping the Future of Breast Cancer Care With Oral SERDs, Genomic Testing, and ctDNA: Rebecca Chacko, MD

Streamlining Breast Cancer Therapy Access for Better Patient Outcomes: Rebecca Chacko, MD

Ovarian, Breast Cancer Disparities Highlight Need for Better Screening: CK Wang, MD

Investigators Advocate for Ongoing Comparison of Cancer Outcomes Among MA, FFS Beneficiaries

No Significant Differences Found in Breast Cancer Treatment Between MA, FFS Beneficiaries: Galen Shearn-Nance, BS

Mixed Outcomes Persist Between MA, FFS Beneficiaries: Johnie Rose, MD, PhD

Collaborative Approaches Provide Comprehensive Support in Cancer Care

TROPION-Breast01: The Evolving Role of TROP2-Directed ADCs in Breast Cancer

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening

The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer

Living Life With Metastatic Breast Cancer From a Male Perspective